OncoMed Pharmaceuticals

About:

OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.

Website: http://www.oncomed.com

Top Investors: Adams Street Partners, U.S. Venture Partners, Morgenthaler Ventures, DeNovo Ventures, Bay Partners

Description:

OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cells”. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.

Total Funding Amount:

$210M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2004-08-01

Contact Email:

bd(AT)oncomed.com

Founders:

Max Wicha, Michael F. Clarke

Number of Employees:

51-100

Last Funding Date:

2013-12-06

IPO Status:

Public

Industries:

© 2025 bioDAO.ai